Physician profile

Mark Levy

Neurological Surgery · Fresno, CA

NPI 1548243389

$450,832.02

in general payments reported to CMS, 2019-2025

12 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Acquisitions$166,666.68
Food and Beverage$27.25

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Omnia Medical, LLC $450,000.01 2021-2024
Abbott Laboratories $329.53 2019-2022
Biogen, INC. $124.99 2019
Boston Scientific Corporation $92.13 2020-2022
Nevro Corp. $63.42 2019-2020
Spineology INC. $59.27 2019
Centinel Spine, LLC $49.62 2019
Stryker Corporation $33.00 2019
Medtronic, INC. $27.25 2023 Capstone Ptc Spinal System
Medtronic USA, INC. $25.78 2020
Vertiflex, INC. $14.07 2019
Arbor Pharmaceuticals, INC. $12.95 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Mark Levy

$450,832.02

in general payments reported 2019-2025

Years
2019-2024
Top company
Omnia Medical, LLC

https://glasscript.com/doctor/114899/mark-levy

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.